Pharmaceutics

Specials system in English primary care no longer delivers best care or value for money

We are writing in response to the news story ‘Pharmacy negotiators say centralised system for specials procurement could “drive down quality”’ (The Pharmaceutical Journal online, 15 May 2019). The current system for specials’ prescription and supply in NHS pr…

Generics manufacturer Bristol Laboratories regains full good manufacturing practice status

Generics manufacturer Bristol Laboratories’ good manufacturing practice status has been fully restored, the company has announced. …

Pharmacy negotiators say centralised system for specials procurement could ‘drive down quality’

The Pharmaceutical Services Negotiating Committee has warned against the government’s suggestion that a centralised system is the “desired future approach” to procuring specials.…

Substandard and falsified medicines: global and local efforts to address a growing problem

Substandard and falsified medicines pose a risk to public health all around the world.…

MHRA issues drug alert for prednisolone tablets after dosage mislabelling in Braille

The Medicines and Healthcare products Regulatory Agency has issued a warning not to supply prednisolone from five batches of 5mg tablets to patients with sight problems following a Braille misprint on the packaging.…

CMA warns drug companies against using discount schemes to maintain market dominance

The Competition and Markets Authority has warned drug companies against using anti-competitive discount schemes to protect dominant market position, after investigating discounts offered by the company that manufactures Remicade.…

FDA approves new generic valsartan to address shortages

The US Food and Drug Administration has approved a new generic valsartan to help relieve recent shortages of the medicine.…

Bulk shipment of medical cannabis delivered to UK

What is thought to be the first bulk shipment of medical cannabis brought into the UK was delivered on 14 February 2019.…

Government drugs advisory body to review impact of medical cannabis reschedule

The Advisory Council for the Misuse of Drugs has been asked by the Home Office to begin a long-term review into cannabis-based products for medical use.…

NHS review finds ‘majority’ of pharmacy aseptic services cannot fund maintenance

Most aseptic pharmacy services in England are unable pay for maintenance and servicing due to a poor understanding of the costs involved, an NHS report has said.…